Douglas M. Singer 13D and 13G filings for Interpace Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 10:49 am Sale | 2025-01-10 | 13G | Interpace Biosciences, Inc. IDXG | Douglas M. Singer | 195,742 4.440% | -31,304 (-13.79%) | Filing |
| 2025-02-14 10:46 am Sale | 2024-12-31 | 13G | Interpace Biosciences, Inc. IDXG | Douglas M. Singer | 227,046 5.150% | -22,954 (-9.18%) | Filing |
| 2024-02-12 5:01 pm Sale | 2023-12-31 | 13G | Interpace Biosciences, Inc. IDXG | Douglas M. Singer | 250,000 5.780% | -105,165 (-29.61%) | Filing |
| 2023-02-10 4:23 pm Purchase | 2022-12-31 | 13G | Interpace Biosciences, Inc. IDXG | Douglas M. Singer | 355,165 8.320% | 62,165 (+21.22%) | Filing |
| 2022-02-10 5:14 pm Purchase | 2022-01-31 | 13G | Interpace Biosciences, Inc. IDXG | Douglas M. Singer | 293,000 6.980% | 293,000 (New Position) | Filing |